Rib Raising for Post-operative Ileus

Sponsor
Rutgers, The State University of New Jersey (Other)
Overall Status
Completed
CT.gov ID
NCT03662672
Collaborator
(none)
102
1
2
11.1
9.2

Study Details

Study Description

Brief Summary

We are conducting a randomized controlled trial the use of rib raising for post-operative ileus. Rib raising is an osteopathic manipulative technique (OMT). We will recruit all patients undergoing major abdominal surgery and once they have been enrolled, we will randomize them to receive daily rib raising or a control technique where we place hands on the back but do not apply any pressure. In preliminary studies, Rib raising has been shown to reduce post-operative ileus and hospital length of stay by up to 50%.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Rib raising and lumbar release
  • Procedure: Sham procedure
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
102 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Treatment
Official Title:
Randomized Controlled Trial of Rib Raising as Early Treatment for Post-operative Ileus
Actual Study Start Date :
Sep 27, 2018
Actual Primary Completion Date :
Aug 15, 2019
Actual Study Completion Date :
Aug 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Rib-raising Intervention

We will do daily rib raising and lumbar release from the 5th thoracic vertebra to the 2nd lumbar vertebra for 2 minutes per side for rib raising and 2 minutes for lumbar release.

Procedure: Rib raising and lumbar release
Rib raising per protocol described in arm description.

Sham Comparator: Sham Intervention

We will do daily sham intervention from the 5th thoracic vertebra to the 2nd lumbar vertebra where we place our hands under the ribs for 2 minutes per side and under the lumbar area for 2 minutes without applying any pressure (or applying pressure into the bed).

Procedure: Sham procedure
Sham procedure per protocol described in arm description

Outcome Measures

Primary Outcome Measures

  1. Length of Stay [0-14 days]

Secondary Outcome Measures

  1. Time to first meal [0-14 days]

  2. Time to first flatus [0-14 days]

  3. Time to first bowel movement [0-14 days]

  4. Need for nasogastric tube postop [0-14 days]

  5. Nausea/vomiting postop [0-14 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 69 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Major abdominal surgery (laparotomy, laparoscopy excluding simple laparoscopic appendectomy or laparoscopic cholecystectomy)
Exclusion Criteria:
  • Open abdomen for >72 hours

  • Prior history of major post-operative complications

  • Intolerance to anesthesia

  • Co-morbidities including osteoporosis and osteopenia

  • Spine or rib fractures

  • Pregnancy

  • Prisoners

  • History of osteopathic manipulation

  • Recruitment delayed beyond 48 hours

  • Surgeon requested exclusion

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital Newark New Jersey United States 07103

Sponsors and Collaborators

  • Rutgers, The State University of New Jersey

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Nina Elizabeth Glass, MD, Assistant Professor, Rutgers, The State University of New Jersey
ClinicalTrials.gov Identifier:
NCT03662672
Other Study ID Numbers:
  • Pro2018001548
First Posted:
Sep 7, 2018
Last Update Posted:
Mar 10, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 10, 2022